Prostatis Group’s iShares MSCI Japan ETF EWJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$551K Sell
5,910
-36,463
-86% -$3.31M 0.13% 108
2026
Q1
$3.58M Sell
42,373
-5,389
-11% -$466K 0.92% 32
2025
Q4
$3.86M Buy
47,762
+4,379
+10% +$360K 0.92% 33
2025
Q3
$3.48M Buy
43,383
+1,723
+4% +$133K 0.87% 36
2025
Q2
$3.12M Buy
+41,660
New +$2.96M 0.89% 28
2023
Q4
Sell
-44,067
Closed -$2.66M 131
2023
Q3
$2.66M Buy
44,067
+8,520
+24% +$526K 1.3% 16
2023
Q2
$2.2M Buy
35,547
+1,813
+5% +$109K 1.02% 24
2023
Q1
$2.02M Buy
+33,734
New +$1.92M 1.06% 21

Other funds holding EWJ

Prostatis Group's EWJ Position: Q2 2026 in Review

Prostatis Group reduced its iShares MSCI Japan ETF (EWJ) stake by 86% in Q2 2026, selling an estimated $3.31M and leaving 5,910 shares worth $551K. The position accounts for 0.13% of the portfolio, ranked #108.

Prostatis Group first reported a position in EWJ in Q1 2023 and has held it in 8 quarters since. The position peaked at $3.86M in Q4 2025. 785 funds tracked by Wall St. Rank hold EWJ as of Q2 2026.

  • Prostatis Group held 5,910 shares of iShares MSCI Japan ETF worth $551K as of Q2 2026.
  • Prostatis Group sold 36,463 iShares MSCI Japan ETF shares in Q2 2026, an estimated $3.31M.
  • iShares MSCI Japan ETF made up 0.13% of Prostatis Group's portfolio in Q2 2026, its #108 holding.
  • Prostatis Group first reported a position in iShares MSCI Japan ETF in Q1 2023 and has held it in 8 quarters since.
  • Prostatis Group's iShares MSCI Japan ETF position peaked at $3.86M in Q4 2025.
  • 785 funds tracked by Wall St. Rank held iShares MSCI Japan ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.